Divergent roles of Slingshot-1 in tauopathy
Divergent roles of Slingshot-1 in tauopathy
批准号:
10293546
负责人:
David E Kang
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-10-01 至 2024-09-30
关键词:
APP-PS1Alzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease modelAmyloid beta-42Amyloid beta-ProteinAnimal ModelApoptosisAutophagocytosisBindingBinding SitesBiochemicalBiologicalBiological AssayBrainC-terminalCatalytic DomainCell modelCellsCo-ImmunoprecipitationsComplexDefectDominant-Negative MutationF-ActinGene ExpressionHomologous GeneHydrogen PeroxideImpairmentKnowledgeLearningLigationLinkLysosomesMediatingMemoryMicrotubulesMitochondriaMolecularMusMutationNeurodegenerative DisordersNeuronsOutcomeOxidative StressPathogenesisPathway interactionsPhosphorylationPlayProcessProtein DephosphorylationProtein phosphataseProteinsPublishingRoleSynapsesSystemTauopathiesTestingVariantViralcofilinin vivoindexinginsightmitochondrial dysfunctionmouse modelmutantneuron lossnovelreceptortau Proteinstau aggregationtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Accumulation of toxic proteins (i.e. Aβ42 & tau) and dysfunctional mitochondria are associated with synaptic and neuronal loss in multiple neurodegenerative disorders, including Alzheimer’s disease (AD). Such clearance defects are thought to arise in large part from deficits in the autophagy-lysosome system. While mounting experimental evidence supports the notion that AD is a tauopathy at least in part driven Aβ, there is still a considerable knowledge gap in the way Aβ and tau pathogenesis are mechanistically connected. Our recently published and preliminary studies indicate that the Slingshot homolog-1 (SSH1) pathway constitutes a critical link between Aβ and tau pathogenesis. SSH1 is a protein phosphatase, classically known for its cofilin dephosphorylating activity. SSH1 is activated by oxidative stress (i.e. H2O2, Aβ, etc.) and/or intracellular Ca2+ elevation, which results in activation / dephosphorylation of cofilin. Activated cofilin can then sever F-actin (at the synapse) and/or translocate to mitochondria to promote mitochondria-mediated apoptosis. Likewise, we have found that activation of SSH1 and cofilin are required for Aβ42-induced mitochondrial dysfunction, synaptic loss, as wells as deficits in LTP and/or learning/memory in cellular and mouse models of A pathogenesis (APP/PS1). In support of these experimental findings, activated cofilin and SSH1/cofilin complexes are increased in APP/PS1 mouse brains as wells as in mitochondria of AD brains. In preliminary studies, we found that in addition to cofilin, SSH1 contains a modular and independent activity on the autophagy cargo receptor p62, which functions to regulate autophagy and tau clearance. By utilizing molecular, biochemical, cell biological, viral, and histochemical tools, we propose to (1) dissect the modular activity of SSH1 in p62-mediated autophagy and mitophagy; and (2) determine the role of SSH1 in p62-mediated autophagy and tauopathy in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fluorescent probes for detection of misfolded protein oligomers in Alzheimer's Disease and related disorders
-
批准号:10604908
-
项目类别:
-
资助金额:$20.04万
-
财政年份:2023
-
负责人:David E Kang
-
依托单位:
Deubiquitinase USP19 in TDP-43 pathogenesis.
-
批准号:10463231
-
项目类别:
-
资助金额:$178.52万
-
财政年份:2022
-
负责人:David E Kang
-
依托单位:
SSH1-Nrf2 nexus in tipping the balance between degeneration and protection in tauopathies.
-
批准号:10605657
-
项目类别:
-
资助金额:$50.57万
-
财政年份:2022
-
负责人:David E Kang
-
依托单位:
Pathological signatures of CHCHD10 dysfunction in ADRDs
-
批准号:10664970
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2021
-
负责人:David E Kang
-
依托单位:
Pathological signatures of CHCHD10 dysfunction in ADRDs
-
批准号:10454350
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2021
-
负责人:David E Kang
-
依托单位:
Deubiquitinase USP11 in tau regulation and age-related tauopathy
-
批准号:10390348
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2020
-
负责人:David E Kang
-
依托单位:
Divergent roles of Slingshot-1 in tauopathy
-
批准号:10514604
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:David E Kang
-
依托单位:
Divergent roles of Slingshot-1 in tauopathy
-
批准号:10006955
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:David E Kang
-
依托单位:
Deubiquitinase USP11 in tau regulation and age-related tauopathy
-
批准号:10170225
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2020
-
负责人:David E Kang
-
依托单位:
Deubiquitinase USP11 in tau regulation and age-related tauopathy
-
批准号:10600991
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2020
-
负责人:David E Kang
-
依托单位:
Deubiquitinase USP11 in tau regulation and age-related tauopathy
-
批准号:10515873
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2020
-
负责人:David E Kang
-
依托单位:
Directional proteome analysis of extracellular vesicles in AD models
-
批准号:9196699
-
项目类别:
-
资助金额:$22.43万
-
财政年份:2016
-
负责人:David E Kang
-
依托单位:
Directional proteome analysis of extracellular vesicles in AD models
-
批准号:9335233
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2016
-
负责人:David E Kang
-
依托单位:
Molecular Intermediates and Regulation of the Abeta-Tau Pathogenic Cascade
-
批准号:9339555
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:David E Kang
-
依托单位:
Molecular Intermediates and Regulation of the Abeta-Tau Pathogenic Cascade
-
批准号:8819391
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:David E Kang
-
依托单位:
Molecular Intermediates and Regulation of the Abeta-Tau Pathogenic Cascade
-
批准号:9985673
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:David E Kang
-
依托单位:
UPR as a Neuronal Death Mediator in Alzheimer's Disease
-
批准号:9280834
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:David E Kang
-
依托单位:
Molecular Intermediates and Regulation of the Abeta-Tau Pathogenic Cascade
-
批准号:9071284
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:David E Kang
-
依托单位:
The hsp90 Cochaperone FKBP51 Regulates tau Structure and Function
-
批准号:9204431
-
项目类别:
-
资助金额:$51.1万
-
财政年份:2011
-
负责人:David E Kang
-
依托单位:
Novel Mechanisms of RanBP9 in APP Pathogenesis
-
批准号:8442409
-
项目类别:
-
资助金额:$20.17万
-
财政年份:2009
-
负责人:David E Kang
-
依托单位: